CTOs on the Move

Renovia Incorporated

www.renoviainc.com

 
Renovia was formed to develop and commercialize products for better first-line diagnosis and treatment to improve the condition-specific quality of life for millions of women with pelvic floor disorders. Renovia`s technology enables treatment via precise visualization of pelvic movement in real-time during pelvic floor muscle training, while monitoring usage and progress over time. As a women`s health organization, Renovia is in pursuit of scalable and cost-effective care for pelvic floor disorders delivered through the power of digital health.
  • Number of Employees: 25-100
  • Annual Revenue: $10-50 Million

Executives

Name Title Contact Details

Funding

Renovia Incorporated raised $17M on 04/19/2021

Similar Companies

Biohit

Biohit is a Neptune, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Equipment Planning Associates Limited

Equipment Planning Associates Limited is a Richmond Hill, ON-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Radlink

Radlink, Inc. is a Redondo Beach, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Cvrx

CVRx® is a private company located in Minneapolis, Minnesota. The company has developed proprietary active implantable technology for the treatment of high blood pressure, also referred to as hypertension, and heart failure. The CVRx senior management and technical team have many years of experience commercializing implantable medical devices. The company is supported by an outstanding board of directors and a world-class scientific advisory board, which includes thought leading physicians and scientists in the field of hypertension and heart failure. CVRx has developed an implantable device that is designed to treat high blood pressure and heart failure. This new device called Barostim neo™ is designed to trigger the body`s own natural blood flow regulation system to treat high blood pressure and heart failure. CVRx has a strong intellectual property foundation, which will protect this unique technology. Barostim neo is CE marked in Europe for the treatment of hypertension patients. It is also CE marked in Europe for the treatment of heart failure. This product is currently under clinical evaluation in the United States and Canada for the treatment of high blood pressure and heart failure.

VALUTEK

VALUTEK is a Phoenix, AZ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.